Indian Pharmacopoeia 2026, 10th Edition, 4 Vols Set Print + Single User Online

Indian Pharmacopoeia 2026: Published By Indian Pharmacopoeia Commission (IPC)

Effective Date : 1st July 2026 (Tentative)

Salient Features:

Total Monographs : 3340
Chemical Monograph : 2579
General Chapter : 242
Excipients : 184
New Monograph : 121

Indian Pharmacopoeia 2026 incorporated 121 new monographs, increasing the total number of Monographs to 3340, Indian Pharmacopoeia expands coverage of Anti-TB, Anti-Diabetic and Anti-Cancer Medicines, as well as iron supplements, thereby ensuring more comprehensive standardization of medicines used under various National Health Programs.

Indian Pharmacopoeia (IP) is published by the Indian Pharmacopoeia Commission (IPC) on behalf of the Ministry of Health & Family Welfare, Government of India in fulfillment of the requirements of the Drugs and Cosmetics Act, 1940 and Rules 1945 there under. IP is recognized as the official book of standards for the drugs being manufactured and/or marketed in India. IP prescribes the official standards for drugs produced and/or marketed in India and thus contributes in the control and assurance of the quality of the medicines. The standards of the IP are authoritative and legally enforceable. It intends to help in the licensing of manufacturing, inspection and distribution of medicines in our country.

Official Book of Drug Standards, Now available in Print & Online Edition.